Drug
Elotuzumab
Elotuzumab: highest development phase Phase 2, developed by Karyopharm Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Karyopharm Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elotuzumab, Selinexor, and Dexamethasone (ESd) NCT05170789 | Phase 2 | Relapsed Multiple Myeloma |
Latest
No recent events.
Follow Elotuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.